CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. SPY
7. CVS
8. UNH
9. DAL
10. TMUS

Go back to CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock

CTI BioPharma (CTIC) Announces Pricing of 50,000 Share Series N-1 Conv. Preferred Stock Offering

October 27, 2015 9:13 AM EDT

CTI BioPharma (NASDAQ: CTIC) announced the pricing of an underwritten public offering of 50,000 shares of its Series N-1 Preferred Stock, offered at a price to the public of $1,000 per share of Series N-1 Preferred Stock (the "Offering"). Each share of Series N-1 Preferred Stock is convertible at the option of the holder, at any time, into 800 shares of common stock at... More

CTI BioPharma (CTIC) Plans Conv. Preferred Offering

October 26, 2015 4:34 PM EDT

CTI BioPharma (NASDAQ: CTIC) announced that it intends to offer and sell, subject to market and other conditions, shares of its Series N-1 Preferred Stock in an underwritten public offering (the "Offering"). Each share of Series N-1 Preferred Stock will have a... More